(Q53758553)

19 May 2018

title

Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. (English)

1 reference

19 May 2018

0 references

Arias F

1

1 reference

19 May 2018

Domínguez MA

2

1 reference

19 May 2018

Martínez E

3

1 reference

19 May 2018

Illarramendi JJ

4

1 reference

19 May 2018

Miquelez S

5

1 reference

19 May 2018

Pascual I

6

1 reference

19 May 2018

Marcos M

7

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

19 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

19 May 2018

volume

47

1 reference

19 May 2018

page(s)

373-378

1 reference

19 May 2018

issue

2

1 reference

19 May 2018

Bladder cancer: long-term follow-up results of patients treated with radical radiation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

The Effect of Radiation and Cytotoxic Platinum Compounds on the Growth of Normal and Tumour Bladder Explant Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Selective bladder preservation by combination treatment of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Bladder preservation and durable complete remission of small cell carcinoma of the bladder with systemic chemotherapy and adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900444-2

7 January 2021

10.1016/S0360-3016(00)00444-2

Identifiers

DOI

1 reference

19 May 2018

PubMed ID

10802362

1 reference

19 May 2018